This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Sally-Anne Rickets
Introduction
Sally-Anne Rickets is a notable inventor based in Amersham, GB. He has made significant contributions to the field of surgical medicine, particularly in the prevention of post-surgical adhesions. His innovative approach has the potential to improve patient outcomes and enhance the healing process.
Latest Patents
Rickets holds a patent for the "Prevention of post surgical adhesions using a fibrin monomer sealant." This invention utilizes a fibrin polymer film that closely resembles natural clotting materials to prevent adhesion formation after surgery. The method involves applying a fibrin monomer under polymerizing conditions directly to the surgical wound site. This approach not only improves adhesion prevention but also functions as a fibrin sealant, promoting hemostasis and wound healing while acting as a barrier. The preferred embodiments of this invention utilize plasma proteins derived from the patient's own blood, ensuring the sealant is autologous and free from added enzymes.
Career Highlights
Sally-Anne Rickets has had a distinguished career, working with Bristol-Myers Squibb Company, where he has been able to apply his innovative ideas in a practical setting. His work has been instrumental in advancing surgical techniques and improving patient care.
Collaborations
Rickets has collaborated with notable colleagues, including Michael J. Amery and Paul David Sibbons. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Sally-Anne Rickets is a pioneering inventor whose work in surgical medicine has the potential to transform patient care. His patented methods for preventing post-surgical adhesions demonstrate his commitment to innovation and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
